Seeking Alpha

CUR
  Neuralstem, Inc. - NYSEMKT

11/26/2014, 9:48 PM ET
  • Robbster | Send Message 28 Sep 2012

    CUR, PSTI, STEM all making steady progress in their respective stages of development. IMUC is in buy range. Biotechs with real results +1
    Reply
      CUR vs. ETF Alternatives
      Company Description
      Neuralstem, Inc. is a biotechnology company. It is engaged in the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States